Looking to publish in Neurodegenerative Disease Management? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.
Existing customer loginNeurodegenerative Disease Management is a MEDLINE-indexed, peer-reviewed journal focused on treatment strategies, emerging research, and multidisciplinary management of neurodegenerative diseases. It covers topics including disease mechanisms, epidemiology, diagnosis, biomarkers, therapeutic options, cognitive impairment and dementia, new treatments such as cell and gene therapy, pharmacoeconomics, real-world evidence, quality of life, and palliative care. Articles are peer reviewed by three independent referees on a double-blind basis, and the journal welcomes unsolicited article proposals.
Looking to publish in Neurodegenerative Disease Management? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.
Existing customer loginSubmission Instructions
Neurodegenerative Disease Management accepts the following article types. Click on an article type to view submission instructions.
Review Articles
Original Research
Drug Evaluation Articles
Recent Publications
RNA interference (RNA)-based therapeutics for treating neurodegenerative diseases
Maryam Mahjoubin-Tehran, Amirhossein Sahebkar
Redefining Parkinson’s disease: microglia and systemic immunity as gateways to early therapy
Alessandro Michelucci, Maria Tziortziou, Anne Grünewald
Survey of the frequency of polypharmacy in multiple sclerosis patients: a study from the nationwide MS registry of Iran (NMSRI)-Guilan
Sahel Asgari, Alia Saberi, Hossein Daliri, Sepideh Atefrad, Mohaya Farzin
Incidence and clinical characteristics of amyotrophic lateral sclerosis during the post-COVID-19 Period: a population-based study from Isfahan, Iran
Masoud Etemadifar, Mehri Salari, Mohammadamin Kashefi, Yalda Shams, Mohammadamin Heydari Sichani, Fatemeh Hojjatipour
Relationship between neck weakness in motor neurone disease and respiratory function: a retrospective study
Timothy P. Sheehy, Trinh Sia, Prue E. Morgan, Yan Zhao, Sally R. Mathieson, Rosanne M. Gibb, Anna A. Smith, Christine A. Wools
Frequently asked questions
How long does it take to publish?
Accelerated Publication offers a final decision in as little as 3 weeks or 9 weeks from submission. Online publication usually occurs 1-2 weeks or 2-3 weeks after acceptance. First proofs are provided within 5 working days.
Reformat to Neurodegenerative Disease Management using Livewrite PremiumIs a cover letter required?
Journals may require authors, prior to acceptance, to sign a letter certifying that legal and ethical requirements for humane animal treatment have been met.
Reformat to Neurodegenerative Disease Management using Livewrite PremiumWhat are the publication costs?
Subscription journal. Individual subscription prices are USD 2,491.00 for online only and USD 3,642.00 for print and online.
Reformat to Neurodegenerative Disease Management using Livewrite Premium